請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/94956完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李建南 | zh_TW |
| dc.contributor.advisor | Chien-Nan Lee | en |
| dc.contributor.author | 黃偉翰 | zh_TW |
| dc.contributor.author | Wei-Han Huang | en |
| dc.date.accessioned | 2024-08-21T16:54:10Z | - |
| dc.date.available | 2024-08-22 | - |
| dc.date.copyright | 2024-08-21 | - |
| dc.date.issued | 2024 | - |
| dc.date.submitted | 2024-07-27 | - |
| dc.identifier.citation | 1. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Human Reproduction. 2009;24(11):2683-7. doi: 10.1093/humrep/dep343.
2. 衛生福利部. 人工生殖施行結果報告. https://wwwhpagovtw/Pages/Listaspx?nodeid=60. 2021. 3. WHO. Infertility prevalence estimates: 1990–2021 World Health Organization. 2023. 4. 內政部戶政司. 初婚者之年齡平均數. https://wwwrisgovtw/app/portal. 2021. 5. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73(6):1155-8. doi: 10.1016/s0015-0282(00)00518-5. PubMed PMID: 10856474. 6. Meseguer M, Herrero J, Tejera A, Hilligsøe KM, Ramsing NB, Remohí J. The use of morphokinetics as a predictor of embryo implantation. Hum Reprod. 2011;26(10):2658-71. Epub 20110809. doi: 10.1093/humrep/der256. PubMed PMID: 21828117. 7. Mio Y, Maeda K. Time-lapse cinematography of dynamic changes occurring during in vitro development of human embryos. Am J Obstet Gynecol. 2008;199(6):660.e1-5. Epub 20080927. doi: 10.1016/j.ajog.2008.07.023. PubMed PMID: 18823872. 8. Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertility and Sterility. 2014;101(3):656-63.e1. doi: 10.1016/j.fertnstert.2013.11.004. 9. Daniely M, Aviram-Goldring A, Barkai G, Goldman B. Detection of chromosomal aberration in fetuses arising from recurrent spontaneous abortion by comparative genomic hybridization. Hum Reprod. 1998;13(4):805-9. doi: 10.1093/humrep/13.4.805. PubMed PMID: 9619528. 10. Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, Wells D. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril. 2010;94(5):1700-6. Epub 20091125. doi: 10.1016/j.fertnstert.2009.10.015. PubMed PMID: 19939370. 11. Munné S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertility and Sterility. 1995;64(2):382-91. doi: 10.1016/s0015-0282(16)57739-5. 12. Fragouli E, Alfarawati S, Spath K, Jaroudi S, Sarasa J, Enciso M, et al. The origin and impact of embryonic aneuploidy. Human Genetics. 2013;132(9):1001-13. doi: 10.1007/s00439-013-1309-0. 13. Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al. Aneuploidy across individual chromosomes at the embryonic level in trophectoderm biopsies: changes with patient age and chromosome structure. Journal of Assisted Reproduction and Genetics. 2014;31(11):1501-9. doi: 10.1007/s10815-014-0333-x. 14. Piette C, de Mouzon J, Bachelot A, Spira A. In-vitro fertilization: influence of women's age on pregnancy rates. Human Reproduction. 1990;5(1):56-9. doi: 10.1093/oxfordjournals.humrep.a137041. 15. Lintsen AM, Eijkemans MJ, Hunault CC, Bouwmans CA, Hakkaart L, Habbema JD, et al. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod. 2007;22(9):2455-62. Epub 20070717. doi: 10.1093/humrep/dem183. PubMed PMID: 17636281. 16. Neal SA, Morin SJ, Franasiak JM, Goodman LR, Juneau CR, Forman EJ, et al. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage. Fertility and Sterility. 2018;110(5):896-904. doi: 10.1016/j.fertnstert.2018.06.021. 17. Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet. 2012;5(1):24. Epub 20120502. doi: 10.1186/1755-8166-5-24. PubMed PMID: 22551456; PubMed Central PMCID: PMC3403960. 18. Scott RT, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertility and Sterility. 2013;100(3):697-703. doi: 10.1016/j.fertnstert.2013.04.035. 19. Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertility and Sterility. 2013;100(1):100-7.e1. doi: 10.1016/j.fertnstert.2013.02.056. 20. Hardy K, Martin KL, Leese HJ, Winston RM, Handyside AH. Human preimplantation development in vitro is not adversely affected by biopsy at the 8-cell stage. Hum Reprod. 1990;5(6):708-14. doi: 10.1093/oxfordjournals.humrep.a137173. PubMed PMID: 2254404. 21. Abdelhadi I, Colls P, Sandalinas M, Escudero T, Munné S. Preimplantation genetic diagnosis of numerical abnormalities for 13 chromosomes. Reprod Biomed Online. 2003;6(2):226-31. doi: 10.1016/s1472-6483(10)61714-2. PubMed PMID: 12676005. 22. Scott RT, Jr., Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril. 2013;100(3):624-30. Epub 20130615. doi: 10.1016/j.fertnstert.2013.04.039. PubMed PMID: 23773313. 23. Mastenbroek S, Twisk M, van der Veen F, Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update. 2011;17(4):454-66. Epub 20110429. doi: 10.1093/humupd/dmr003. PubMed PMID: 21531751. 24. Wells D, Sherlock JK, Handyside AH, Delhanty JD. Detailed chromosomal and molecular genetic analysis of single cells by whole genome amplification and comparative genomic hybridisation. Nucleic Acids Res. 1999;27(4):1214-8. doi: 10.1093/nar/27.4.1214. PubMed PMID: 9927758; PubMed Central PMCID: PMC148305. 25. Voullaire L, Wilton L, Slater H, Williamson R. Detection of aneuploidy in single cells using comparative genomic hybridization. Prenat Diagn. 1999;19(9):846-51. PubMed PMID: 10521843. 26. Hellani A, Abu-Amero K, Azouri J, El-Akoum S. Successful pregnancies after application of array-comparative genomic hybridization in PGS-aneuploidy screening. Reprod Biomed Online. 2008;17(6):841-7. doi: 10.1016/s1472-6483(10)60413-0. PubMed PMID: 19079969. 27. Aleksandrova N, Shubina E, Ekimov A, Kodyleva T, Mukosey I, Makarova N, et al. Comparison of the results of preimplantation genetic screening obtained by a-CGH and NGS methods from the same embryos. Gynecol Endocrinol. 2016;32(sup2):1-4. doi: 10.1080/09513590.2016.1232892. PubMed PMID: 27759447. 28. Friedenthal J, Maxwell SM, Munné S, Kramer Y, McCulloh DH, McCaffrey C, et al. Next generation sequencing for preimplantation genetic screening improves pregnancy outcomes compared with array comparative genomic hybridization in single thawed euploid embryo transfer cycles. Fertil Steril. 2018;109(4):627-32. Epub 20180328. doi: 10.1016/j.fertnstert.2017.12.017. PubMed PMID: 29605407. 29. Fiorentino F, Biricik A, Bono S, Spizzichino L, Cotroneo E, Cottone G, et al. Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos. Fertil Steril. 2014;101(5):1375-82. Epub 20140306. doi: 10.1016/j.fertnstert.2014.01.051. PubMed PMID: 24613537. 30. Kung A, Munné S, Bankowski B, Coates A, Wells D. Validation of next-generation sequencing for comprehensive chromosome screening of embryos. Reprod Biomed Online. 2015;31(6):760-9. Epub 20150909. doi: 10.1016/j.rbmo.2015.09.002. PubMed PMID: 26520420. 31. Munné S, Kaplan B, Frattarelli JL, Child T, Nakhuda G, Shamma FN, et al. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019;112(6):1071-9.e7. Epub 20190921. doi: 10.1016/j.fertnstert.2019.07.1346. PubMed PMID: 31551155. 32. Pagliardini L, Viganò P, Alteri A, Corti L, Somigliana E, Papaleo E. Shooting STAR: reinterpreting the data from the 'Single Embryo TrAnsfeR of Euploid Embryo' randomized clinical trial. Reprod Biomed Online. 2020;40(4):475-8. Epub 20200125. doi: 10.1016/j.rbmo.2020.01.015. PubMed PMID: 32273162. 33. Zhang WY, von Versen-Höynck F, Kapphahn KI, Fleischmann RR, Zhao Q, Baker VL. Maternal and neonatal outcomes associated with trophectoderm biopsy. Fertil Steril. 2019;112(2):283-90.e2. Epub 20190515. doi: 10.1016/j.fertnstert.2019.03.033. PubMed PMID: 31103283; PubMed Central PMCID: PMC6527329. 34. Aoyama N, Kato K. Trophectoderm biopsy for preimplantation genetic test and technical tips: A review. Reprod Med Biol. 2020;19(3):222-31. Epub 20200126. doi: 10.1002/rmb2.12318. PubMed PMID: 32684821; PubMed Central PMCID: PMC7360970. 35. Rubino P, Tapia L, Ruiz de Assin Alonso R, Mazmanian K, Guan L, Dearden L, et al. Trophectoderm biopsy protocols can affect clinical outcomes: time to focus on the blastocyst biopsy technique. Fertil Steril. 2020;113(5):981-9. Epub 20200320. doi: 10.1016/j.fertnstert.2019.12.034. PubMed PMID: 32204876. 36. Guzman L, Nuñez D, López R, Inoue N, Portella J, Vizcarra F, et al. The number of biopsied trophectoderm cells may affect pregnancy outcomes. J Assist Reprod Genet. 2019;36(1):145-51. Epub 20181017. doi: 10.1007/s10815-018-1331-1. PubMed PMID: 30328573; PubMed Central PMCID: PMC6338600. 37. Carbone L, Chavez SL. Mammalian pre-implantation chromosomal instability: species comparison, evolutionary considerations, and pathological correlations. Syst Biol Reprod Med. 2015;61(6):321-35. Epub 20150914. doi: 10.3109/19396368.2015.1073406. PubMed PMID: 26366555; PubMed Central PMCID: PMC7857118. 38. Bedzhov I, Graham SJ, Leung CY, Zernicka-Goetz M. Developmental plasticity, cell fate specification and morphogenesis in the early mouse embryo. Philos Trans R Soc Lond B Biol Sci. 2014;369(1657). doi: 10.1098/rstb.2013.0538. PubMed PMID: 25349447; PubMed Central PMCID: PMC4216461. 39. Munné S, Weier HU, Grifo J, Cohen J. Chromosome mosaicism in human embryos. Biol Reprod. 1994;51(3):373-9. doi: 10.1095/biolreprod51.3.373. PubMed PMID: 7803609. 40. Harper JC, Coonen E, Handyside AH, Winston RM, Hopman AH, Delhanty JD. Mosaicism of autosomes and sex chromosomes in morphologically normal, monospermic preimplantation human embryos. Prenat Diagn. 1995;15(1):41-9. doi: 10.1002/pd.1970150109. PubMed PMID: 7739996. 41. Capalbo A, Rienzi L. Mosaicism between trophectoderm and inner cell mass. Fertil Steril. 2017;107(5):1098-106. Epub 20170419. doi: 10.1016/j.fertnstert.2017.03.023. PubMed PMID: 28433375. 42. Lee CI, Cheng EH, Lee MS, Lin PY, Chen YC, Chen CH, et al. Healthy live births from transfer of low-mosaicism embryos after preimplantation genetic testing for aneuploidy. J Assist Reprod Genet. 2020;37(9):2305-13. Epub 20200704. doi: 10.1007/s10815-020-01876-6. PubMed PMID: 32623662; PubMed Central PMCID: PMC7492347. 43. Maxwell SM, Colls P, Hodes-Wertz B, McCulloh DH, McCaffrey C, Wells D, et al. Why do euploid embryos miscarry? A case-control study comparing the rate of aneuploidy within presumed euploid embryos that resulted in miscarriage or live birth using next-generation sequencing. Fertil Steril. 2016;106(6):1414-9.e5. Epub 20160928. doi: 10.1016/j.fertnstert.2016.08.017. PubMed PMID: 27692437. 44. Chuang TH, Chang YP, Lee MJ, Wang HL, Lai HH, Chen SU. The Incidence of Mosaicism for Individual Chromosome in Human Blastocysts Is Correlated With Chromosome Length. Front Genet. 2020;11:565348. Epub 20210106. doi: 10.3389/fgene.2020.565348. PubMed PMID: 33488666; PubMed Central PMCID: PMC7815765. 45. Armstrong A, Kroener L, Miller J, Nguyen A, Kwan L, Quinn M. The nature of embryonic mosaicism across female age spectrum: an analysis of 21,345 preimplantation genetic testing for aneuploidy cycles. F S Rep. 2023;4(3):256-61. Epub 20230408. doi: 10.1016/j.xfre.2023.03.008. PubMed PMID: 37719098; PubMed Central PMCID: PMC10504531. 46. Vera-Rodriguez M, Rubio C. Assessing the true incidence of mosaicism in preimplantation embryos. Fertil Steril. 2017;107(5):1107-12. Epub 20170419. doi: 10.1016/j.fertnstert.2017.03.019. PubMed PMID: 28433370. 47. Shamonki MI, Jin H, Haimowitz Z, Liu L. Proof of concept: preimplantation genetic screening without embryo biopsy through analysis of cell-free DNA in spent embryo culture media. Fertility and Sterility. 2016;106(6):1312-8. doi: 10.1016/j.fertnstert.2016.07.1112. 48. Xu J, Fang R, Chen L, Chen D, Xiao J-P, Yang W, et al. Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization. Proceedings of the National Academy of Sciences. 2016;113(42):11907-12. doi: 10.1073/pnas.1613294113. 49. Gianaroli L, Magli MC, Pomante A, Crivello AM, Cafueri G, Valerio M, et al. Blastocentesis: a source of DNA for preimplantation genetic testing. Results from a pilot study. Fertility and Sterility. 2014;102(6):1692-9.e6. doi: 10.1016/j.fertnstert.2014.08.021. 50. Leaver M, Wells D. Non-invasive preimplantation genetic testing (niPGT): the next revolution in reproductive genetics? Human Reproduction Update. 2020;26(1):16-42. doi: 10.1093/humupd/dmz033. 51. Brouillet S, Martinez G, Coutton C, Hamamah S. Is cell-free DNA in spent embryo culture medium an alternative to embryo biopsy for preimplantation genetic testing? A systematic review. Reproductive BioMedicine Online. 2020;40(6):779-96. doi: 10.1016/j.rbmo.2020.02.002. 52. Hammond ER, McGillivray BC, Wicker SM, Peek JC, Shelling AN, Stone P, et al. Characterizing nuclear and mitochondrial DNA in spent embryo culture media: genetic contamination identified. Fertility and Sterility. 2017;107(1):220-8.e5. doi: 10.1016/j.fertnstert.2016.10.015. 53. Hanson BM, Tao X, Hong KH, Comito CE, Pangasnan R, Seli E, et al. Noninvasive preimplantation genetic testing for aneuploidy exhibits high rates of deoxyribonucleic acid amplification failure and poor correlation with results obtained using trophectoderm biopsy. Fertility and Sterility. 2021;115(6):1461-70. doi: 10.1016/j.fertnstert.2021.01.028. 54. Ho JR, Arrach N, Rhodes-Long K, Ahmady A, Ingles S, Chung K, et al. Pushing the limits of detection: investigation of cell-free DNA for aneuploidy screening in embryos. Fertility and Sterility. 2018;110(3):467-75.e2. doi: 10.1016/j.fertnstert.2018.03.036. 55. Kang X, Wen M, Zheng J, Peng F, Zeng N, Chen Z, et al. Influence of the number of washings for embryos on non-invasive preimplantation chromosome screening results. Frontiers in Endocrinology. 2024;15. doi: 10.3389/fendo.2024.1363851. 56. Yeung QSY, Zhang YX, Chung JPW, Lui WT, Kwok YKY, Gui B, et al. A prospective study of non-invasive preimplantation genetic testing for aneuploidies (NiPGT-A) using next-generation sequencing (NGS) on spent culture media (SCM). Journal of Assisted Reproduction and Genetics. 2019;36(8):1609-21. doi: 10.1007/s10815-019-01517-7. 57. Rubio C, Rienzi L, Navarro-Sánchez L, Cimadomo D, García-Pascual CM, Albricci L, et al. Embryonic cell-free DNA versus trophectoderm biopsy for aneuploidy testing: concordance rate and clinical implications. Fertility and Sterility. 2019;112(3):510-9. doi: 10.1016/j.fertnstert.2019.04.038. 58. Rubio C, Navarro-Sánchez L, García-Pascual CM, Ocali O, Cimadomo D, Venier W, et al. Multicenter prospective study of concordance between embryonic cell-free DNA and trophectoderm biopsies from 1301 human blastocysts. American Journal of Obstetrics and Gynecology. 2020;223(5):751.e1-.e13. doi: 10.1016/j.ajog.2020.04.035. 59. Vera-Rodriguez M, Diez-Juan A, Jimenez-Almazan J, Martinez S, Navarro R, Peinado V, et al. Origin and composition of cell-free DNA in spent medium from human embryo culture during preimplantation development. Human Reproduction. 2018;33(4):745-56. doi: 10.1093/humrep/dey028. 60. Xu J, Fang R, Chen L, Chen D, Xiao JP, Yang W, et al. Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization. Proc Natl Acad Sci U S A. 2016;113(42):11907-12. Epub 20160929. doi: 10.1073/pnas.1613294113. PubMed PMID: 27688762; PubMed Central PMCID: PMC5081593. 61. Chen L, Sun Q, Xu J, Fu H, Liu Y, Yao Y, et al. A Non-invasive Chromosome Screening Strategy for Prioritizing in vitro Fertilization Embryos for Implantation. Frontiers in Cell and Developmental Biology. 2021;9. doi: 10.3389/fcell.2021.708322. 62. Neal SA, Sun L, Jalas C, Morin SJ, Molinaro TA, Scott RT, Jr. When next-generation sequencing-based preimplantation genetic testing for aneuploidy (PGT-A) yields an inconclusive report: diagnostic results and clinical outcomes after re biopsy. J Assist Reprod Genet. 2019;36(10):2103-9. Epub 20190830. doi: 10.1007/s10815-019-01550-6. PubMed PMID: 31471748; PubMed Central PMCID: PMC6823328. 63. Carles M, Sonigo C, Binois O, Hesters L, Steffann J, Romana S, et al. Second biopsy for embryos with inconclusive results after preimplantation genetic testing: Impact on pregnancy outcomes. J Gynecol Obstet Hum Reprod. 2022;51(8):102436. Epub 20220703. doi: 10.1016/j.jogoh.2022.102436. PubMed PMID: 35793773. 64. Nohales M, Coello A, Martin A, Insua F, Meseguer M, de Los Santos MJ. Should embryo rebiopsy be considered a regular strategy to increase the number of embryos available for transfer? J Assist Reprod Genet. 2023;40(8):1905-13. Epub 20230711. doi: 10.1007/s10815-023-02875-z. PubMed PMID: 37432589; PubMed Central PMCID: PMC10371936. 65. Leigh D, Cram DS, Rechitsky S, Handyside A, Wells D, Munne S, et al. PGDIS position statement on the transfer of mosaic embryos 2021. Reprod Biomed Online. 2022;45(1):19-25. Epub 20220320. doi: 10.1016/j.rbmo.2022.03.013. PubMed PMID: 35523707. 66. Tsai N-C, Chang Y-C, Su Y-R, Lin Y-C, Weng P-L, Cheng Y-H, et al. Validation of Non-Invasive Preimplantation Genetic Screening Using a Routine IVF Laboratory Workflow. Biomedicines. 2022;10(6). doi: 10.3390/biomedicines10061386. 67. Handayani N, Aubry D, Boediono A, Bowolaksono A, Sini I, Haq NMD, et al. Non-Invasive Pre-implantation Genetic Testing's Reliability for Aneuploidy using Cell-free DNA in Embryo Culture Media. J Gynecol Obstet Hum Reprod. 2024:102808. Epub 20240531. doi: 10.1016/j.jogoh.2024.102808. PubMed PMID: 38825167. 68. Singla S, Iwamoto-Stohl LK, Zhu M, Zernicka-Goetz M. Autophagy-mediated apoptosis eliminates aneuploid cells in a mouse model of chromosome mosaicism. Nat Commun. 2020;11(1):2958. Epub 20200611. doi: 10.1038/s41467-020-16796-3. PubMed PMID: 32528010; PubMed Central PMCID: PMC7290028. 69. Domingo-Muelas A, Skory RM, Moverley AA, Ardestani G, Pomp O, Rubio C, et al. Human embryo live imaging reveals nuclear DNA shedding during blastocyst expansion and biopsy. Cell. 2023;186(15):3166-81.e18. Epub 20230705. doi: 10.1016/j.cell.2023.06.003. PubMed PMID: 37413989; PubMed Central PMCID: PMC11170958. 70. Tsai NC, Chang YC, Su YR, Lin YC, Weng PL, Cheng YH, et al. Validation of Non-Invasive Preimplantation Genetic Screening Using a Routine IVF Laboratory Workflow. Biomedicines. 2022;10(6). Epub 20220611. doi: 10.3390/biomedicines10061386. PubMed PMID: 35740408; PubMed Central PMCID: PMC9219764. 71. Nakhuda G, Rodriguez S, Tormasi S, Welch C. A pilot study to investigate the clinically predictive values of copy number variations detected by next-generation sequencing of cell-free deoxyribonucleic acid in spent culture media. Fertility and Sterility. 2024. doi: 10.1016/j.fertnstert.2024.02.030. 72. Navarro-Sánchez L, García-Pascual C, Rubio C, Simón C. Non-invasive preimplantation genetic testing for aneuploidies: an update. Reproductive BioMedicine Online. 2022;44(5):817-28. doi: 10.1016/j.rbmo.2022.01.012. 73. Chen L, Li W, Liu Y, Peng Z, Cai L, Zhang N, et al. Non-invasive embryo selection strategy for clinical IVF to avoid wastage of potentially competent embryos. Reprod Biomed Online. 2022;45(1):26-34. Epub 20220311. doi: 10.1016/j.rbmo.2022.03.006. PubMed PMID: 35537927. 74. Chen C-K, Huang W-H, Chang TA, Chao K-H, Chiang W-F, Yeh H-Y, et al. Implementation of Noninvasive Preimplantation Genetic Testing for Aneuploidy with Spent Blastocyst Medium into Clinical and Laboratory Practice: The First Successful Experience in Taiwan. Fertility & Reproduction. 2023;05(01):73-7. doi: 10.1142/s2661318223720015. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/94956 | - |
| dc.description.abstract | 不孕症為高度開發國家面臨到的問題，最根本的原因在於晚婚與晚生育，目前主要是透過人工生殖的方式進行治療，然而挑選合適的胚胎進行植入為最重要的一步。目前最常使用的方式是根據胚胎型態學進行挑選，但是傳統的胚胎學並不能了解胚胎染色體組成，許多研究指出，早期流產很大原因在於染色體的非整倍性。目前篩選胚胎染色體的方式為胎植入前染色體篩檢Preimplantation genetic testing for aneuploidy (PGT-A)，根據滋養外胚層切下來的細胞進行分析，進而推估胚胎的染色體組成，但是切片需要高技術人員操作，以及切片衍生的鑲嵌體問題，還有是否會造成胚胎損傷等問題，都是可能的潛在風險。因此，非侵入性胚胎植入前染色體篩檢Non-invasive preimplantation genetic testing for aneuploidy (niPGT-A)被視為，可以替代PGT-A的方案之一。
本次研究從祈新婦產科診所收集了180顆胚胎進行分析，初步先確定拋棄的胚胎培養液的收集流程，在全基因放大成功率、次世代定序成功率、染色體一致率，有達到近年文獻上的標準，再以此收集流程應用在臨床的實驗流程上，結果發現培養到第五天所收集的胚胎培養液，顯示出較低的全基因放大成功率、次世代定序成功率、染色體一致率，延長培養到第六天後結果有改善。另外我們也根據胚胎的型態學結合一致率進行分析，結果顯示胚胎的膨脹程度與一致率呈現正相關，結論是胚胎的培養時間及胚胎的膨脹程度，會影響到胚胎DNA的釋出。 最後，雖然niPGT-A目前還不能取代傳統PGT-A，但可以當作一個替代方案使用，在反覆PGT-A失敗的個案，可以考慮使用，並相信後續會有更多研究投入，進一步的改善niPGT-A的使用體驗。 | zh_TW |
| dc.description.abstract | Infertility is a significant problem in developed countries, primarily due to late marriage and delayed childbearing. Currently, the main method of treatment is through artificial reproduction, and the most important step is selecting suitable embryos for implantation. The traditional method of selecting embryos base on morphology does not provide information about the embryo chromosomal composition. Many studies have shown that a large proportion of early miscarriages is due to chromosomal aneuploidy. Preimplantation genetic testing for aneuploidy (PGT-A) is currently used to screen embryos for chromosomal abnormalities by analyzing cells from a trophectoderm biopsy (TE). however, TE biopsy requires skilled embryologists and has potential risks, including mosaicism and potential damage to the embryos. Therefore, Non-invasive preimplantation genetic testing for aneuploidy (niPGT-A) is being considered as an alternative to PGT-A. Initially, the process of collecting spent culture medium (SBM) was confirmed to meet recent literature standards in terms of whole genome amplification (WGA) success rate, next-generation sequencing (NGS) success rate, and chromosomal concordance rate. This collection process was then applied to clinical experimental workflow. The results showed that the SBM collected on day 5 of culture had a lower WGA success rate, NGS success rate, and chromosomal concordance rate, and extending the culture to the day 6 showed improvements. Additionally, we analyzed the correlation between embryo morphology and concordance rate. The results indicated a positive correlation between embryo expansion and concordance rate. The conclusion is that the culture time and embryo expansion affect the release of embryonic DNA.
Finally, although niPGT-A cannot currently replace traditional PGT-A, it can be used as an alternative. In cases of repeated PGT-A failures, niPGT-A can be considered. It is believed that more research will be invested in the future to further improve niPGT-A. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2024-08-21T16:54:10Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2024-08-21T16:54:10Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 目次
口試委員審定書 i 誌謝 ii 中文摘要 iii 英文摘要 iv 第一章 研究介紹 1 第一節 不孕症 1 第二節 人工生殖 1 第三節 胚胎植入前染色體篩檢 2 第四節 非侵入胚胎植入前染色體篩檢 4 第五節 研究動機 7 第二章 材料方法 8 第三章 研究結果 17 第一節 預實驗結果 17 第二節 臨床條件下培養液結果分析 22 第三節 胚胎型態與 niPGTA 相關性 25 第四節 臨床植入懷孕率 33 第五節 結論 34 第四章 討論 36 第五章 侷限性 38 第六章 參考文獻 39 | - |
| dc.language.iso | zh_TW | - |
| dc.title | 非侵入胚胎植入前染色體篩檢： 基於胚胎膨脹程度與培養液收集之策略 | zh_TW |
| dc.title | Non-invasive preimplantation genetic testing for aneuploidy: a new medium collection strategy based on blastocyst | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 112-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 陳思原;林芯伃 | zh_TW |
| dc.contributor.oralexamcommittee | Shee-Uan Chen;Shin-Yu Lin | en |
| dc.subject.keyword | 胚胎植入前染色體篩檢,非侵入性胚胎植入前染色體篩檢,拋棄的胚胎培養液,次世代定序,人工生殖, | zh_TW |
| dc.subject.keyword | Non-invasive preimplantation genetic testing for aneuploidy,Preimplantation genetic testing for aneuploidy,Spent culture medium,Next Generation Sequencing,In vitro fertilization, | en |
| dc.relation.page | 50 | - |
| dc.identifier.doi | 10.6342/NTU202402422 | - |
| dc.rights.note | 同意授權(全球公開) | - |
| dc.date.accepted | 2024-07-29 | - |
| dc.contributor.author-college | 醫學院 | - |
| dc.contributor.author-dept | 臨床醫學研究所 | - |
| 顯示於系所單位： | 臨床醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-112-2.pdf 此日期後於網路公開 2029-07-27 | 1.99 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。